Cardiac transplantation: The Stanford experience in the cyclosporine era
Open Access
- 1 August 1994
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 108 (2) , 240-252
- https://doi.org/10.1016/s0022-5223(94)70006-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant RecipientsNew England Journal of Medicine, 1993
- Transplant coronary artery disease: Histopathologic correlations with angiographic morphologyJournal of the American College of Cardiology, 1991
- Cardiac Retransplantation in the Cyclosporine EraThe Annals of Thoracic Surgery, 1989
- A PROSPECTIVE COMPARISON OF MURINE MONOCLONAL CD-3 (OKT3) ANTIBODY-BASED AND EQUINE ANTITHYMOCYTE GLOBULIN-BASED REJECTION PROPHYLAXIS IN CARDIAC TRANSPLANTATIONTransplantation, 1989
- Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.Circulation, 1987
- HLA Compatibility and Cardiac Transplant Recipient SurvivalThe Annals of Thoracic Surgery, 1987
- Cardiac transplantation in patients over 50 years of ageJournal of the American College of Cardiology, 1986
- Cardiac homotransplantationCurrent Problems in Surgery, 1979
- Determinants of operative risk in human heart transplantationThe American Journal of Surgery, 1971
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958